Anyone think Sanofi will buyout or partner with Mannkind
Sentiment: Strong Buy
If they don't have a seat at the Afrezza negotiating table that is happening RIGHT NOW, Sanofi are fools.
SNY would benefit BIGTIME in either scenario.......an absolute no brainer.
MNKD may be a little risky at the mo. I would sat partnership with BIOD
risky you really think afrezza not going to get approved. im a type 1 and believe me we need a rapid fast acting insulin now